Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease? - Wikidata - awgldk - TriplyDB

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

http://www.wikidata.org/entity/Q36188726

about

Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan.Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy.Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson's disease.Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies.Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain.Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration.

P2860

Q33821908-7F839EF9-D1B2-4680-BF7C-27F2C8970817 Q34725080-8F371E56-C1DA-43A5-8172-E8DEFD202AC3 Q35566604-285E7F7A-BAA3-4B18-81FB-C03AE5C26277 Q37855572-31E3B091-9CAD-4F93-AA4C-FD6E04B7DB12 Q37962621-6EA82853-432C-4666-A8EA-8D11395D7EE1 Q46035772-72B47B82-4F9B-400F-B375-CE73F61EEA42 Q46654865-81318FFE-C64D-45D0-A18F-21E8C9A20BE7

P2860

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

http://www.wikidata.org/entity/Q36188726

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

@ast

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

@en

type

label

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

@ast

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

@en

prefLabel

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

@ast

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

@en

P1433

Q36188726-10AFDD70-CAC3-4CE9-8F17-A383EED21C6D

P1476

Q36188726-34CA25FF-4CA9-4F85-AD31-856727FC59B4

P2093

Q36188726-270D19E1-1EF1-4002-86FA-F1E1E7DBF7A0

P2860

Q36188726-01002B01-2B4E-4A21-B152-9778C31BACAB

Q36188726-22814BFB-FA10-405E-B677-E99330FE880D

Q36188726-37B3C9C6-A0CA-4E05-99B5-FA70A8B936FA

Q36188726-6D162759-63ED-4296-836D-70F5810757FB

Q36188726-7409B509-9C9B-4ABF-872F-050025552A24

Q36188726-91DE7275-2C61-49DF-B4DB-0E313E018735

P304

Q36188726-28A7763E-BA29-469B-818F-1AF7D098A782

P31

Q36188726-AC2CC56B-6725-4B54-9CE8-2DC5B25A0332

P356

Q36188726-002E920D-0108-487A-8A72-DA852D155C48

P433

Q36188726-17930DC5-006B-430C-9204-D9E308970634

P478

Q36188726-543C0A84-CC45-4E2D-A7C3-6EBA0E7E0F82

P577

Q36188726-3F2217B7-D4D4-4C40-B688-AFDB2F7B69EE

P5875

Q36188726-B52F0D30-3809-407A-88E3-39910045D612

P698

Q36188726-AB397827-5E0E-4BA7-84A6-BB613F0698C4

P921

Q36188726-80DC77A2-39BF-407A-BC67-595EB2F5B67E

P932

Q36188726-8B35C724-6863-43AD-9244-CD7B99B4C1D7

P356

J.1527-3458.2005.TB00269.X

P1433

CNS Neuroscience & Therapeutics

P1476

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

@en

P2093

Fabio Blandini

http://www.w3.org/2001/XMLSchema#string

P2860

The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury.

Clinical applications of MAO-inhibitors.

Clinical trials of neuroprotection for Parkinson's disease.

A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease.

Deprenyl is metabolized to methamphetamine and amphetamine in man.

Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients.

P304

183-194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1527-3458.2005.TB00269.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7737788

http://www.w3.org/2001/XMLSchema#string

P698

16007239

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

6741719

http://www.w3.org/2001/XMLSchema#string